Atherosclerosis plaque area reduction: working hypothesis to prevent cardiovascular event
- 47 Downloads
Cardiovascular events are the leading cause of death worldwide. In this sense, cardiovascular diseases (CVD) are the main products of atherosclerosis (ATR), whose origin is multifactorial. The measurable identification of the so-called cardiovascular risk factors (CRF) was a great advance for its prevention. Scientific evidences have shown that the reduction of mortality due to cardiovascular disease is an important achievement of the optimal control of CRF. However, a large proportion of patients have cardiovascular events when CRF is controlled. It is therefore imperative to stratify the patient’s risk in order to design the specific and individual treatment strategy. Currently, there are cardiovascular risk classification (CVR) scales that contemplate the combination of the multiple CRF that patients may present, although it is known that most of these algorithms sub- or overestimate the possibility of cardiovascular events. The incorporation of intermediate cardiovascular surrogates to CRF and events, such as the measurement of carotid atherosclerosis, is demonstrating an improvement in the diagnosis and fewer events in the healthy population, with high cardiovascular risk, treated with the incorporation of these to the diagnostic and therapeutic algorithms.
KeywordsPrevention of cardiovascular event Carotid atherosclerosis Vascular Doppler Hypertension Prevention diet therapy
The authors acknowledge CONICET, the Argentine Society of Arterial Hypertension, and Blossom DMO for their support in grants.
This study was funded by CONICET (grant numbers: Res4541/12 and PIP 2013-2015GI), the Argentine Society of Arterial Hypertension, and Blossom DMO.
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
- Adams, A (2014). Carotid total plaque area is a better tool for risk stratification in primary prevention than the PROCAM-Score or the measurement of IMT. ASU international. 49. https://doi.org/10.17147/ASUI.2014-10-01-04
- Atkins PW, Pérez HA, Spence JD, Muñoz SE, Armando LJ, García NH. Increased carotid plaque burden in patients with a family history of premature cardiovascular events in the absence of classical risk factors. AMS-07635-2017-04 2018. In pressGoogle Scholar
- de Ruijter W, Westendorp RGJ, Assendelft WJJ, den Elzen WPJ, de Craen AJM, le Cessie S, Gussekloo J (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study BMJ; 338 :a3083Google Scholar
- Fransson EI, Nyberg ST, Heikkilä K, Alfredsson L, Bjorner JB, Borritz M, Burr H, Dragano N, Geuskens GA, Goldberg M, Hamer M, Hooftman WE, Houtman IL, Joensuu M, Jokela M, Knutsson A, Koskenvuo M, Koskinen A, Kumari M, Leineweber C, Lunau T, Madsen IEH, Hanson LLM, Nielsen ML, Nordin M, Oksanen T, Pentti J, Pejtersen JH, Rugulies R, Salo P, Shipley MJ, Steptoe A, Suominen SB, Theorell T, Toppinen-Tanner S, Vahtera J, Virtanen M, Väänänen A, Westerholm PJM, Westerlund H, Zins M, Britton A, Brunner EJ, Singh-Manoux A, Batty GD, Kivimäki M (2015) Job strain and the risk of stroke: an individual-participant data meta-analysis. Stroke 46(2):557–559CrossRefPubMedGoogle Scholar
- Gepner AD, Young R, Delaney JA, Tattersall MC, Blaha MJ, Post WS, Gottesman RF, Kronmal R, Budoff MJ, Burke GL, Folsom AR, Liu K, Kaufman J, Stein JH (2015) Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 8(1)Google Scholar
- Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, Donner A, Mamdani M, Douketis JD, Arima H, Chalmers J, MacMahon S, Tirschwell DL, Psaty BM, Bushnell CD, Aguilar MI, Capampangan DJ, Werring DJ, De Rango P, Viswanathan A, Danchin N, Cheng CL, Yang YHK, Verdel BM, Lai MS, Kennedy J, Uchiyama S, Yamaguchi T, Ikeda Y, Mrkobrada M (2011) Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation 124(20):2233–2242CrossRefPubMedGoogle Scholar
- Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, Go AS, Harrell FE, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC, Wilson PWF, on behalf of the American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council (2009) Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119(17):2408–2416CrossRefPubMedPubMedCentralGoogle Scholar
- Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Løchen ML, Njølstad I, Arnesen E (2007) Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø study. Stroke 38(11):2873–2880CrossRefPubMedGoogle Scholar
- Jorstad HT, Colkesen EB, Minneboo M, Peters RJ, Boekholdt SM, Tijssen JG, Wareham NJ, Khaw KT (2015) The Systematic COronary Risk Evaluation (SCORE) in a large UK population: 10-year follow-up in the EPIC-Norfolk prospective population study. Eur J Prev Cardiol 22(1):119–126CrossRefPubMedGoogle Scholar
- Kivimaki M, Tabak AG, Batty GD, Ferrie JE, Nabi H, Marmot MG, Witte DR, Singh-Manoux A, Shipley MJ (2010) Incremental predictive value of adding past blood pressure measurements to the Framingham hypertension risk equation: the Whitehall II study. Hypertension 55(4):1058–1062CrossRefPubMedPubMedCentralGoogle Scholar
- Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield MJ, Devlin JJ, Nordio F, Hyde CL, Cannon CP, Sacks FM, Poulter NR, Sever PS, Ridker PM, Braunwald E, Melander O, Kathiresan S, Sabatine MS. (2015) Genetic risk, coronary heart disease events, and the clinical benefit 569 of statin therapy: an analysis of primary and secondary prevention trials. Lancet 385 (9984): 2264-2271Google Scholar
- Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, Volcik K, Boerwinkle E, Ballantyne CM (2010) Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 55(15):1600–1607CrossRefPubMedPubMedCentralGoogle Scholar
- Naqvi TZ, Mendoza F, Rafii F, Gransar H, Guerra M, Lepor N, Berman DS, Shah PK (2010) High prevalence of ultrasound detected carotid atherosclerosis in subjects with low Framingham risk score: potential implications for screening for subclinical atherosclerosis. J Am Soc Echocardiogr 23(8):809–815CrossRefPubMedGoogle Scholar
- Perez HA, Garcia NH, Spence JD, Armando LJ (2016) Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification. ArchMed Sci 12(3):513–520Google Scholar
- Polak JF, Pencina MJ, Meisner A, Pencina KM, Brown LS, Wolf PA, DGÇÖAgostino RB (2010) Associations of carotid artery intima-media thickness (IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotid artery IMT with maximum internal carotid artery IMT. J Ultrasound Med 29(12):1759–1768CrossRefPubMedPubMedCentralGoogle Scholar
- Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195–2207CrossRefPubMedGoogle Scholar
- Romanens M, Ackermann F, Spence JD, Darioli R, Rodondi N, Corti R, Noll G, Schwenkglenks M, Pencina M (2010) Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics. Eur J Cardiovasc Prev Rehabil 17(1):18–23CrossRefPubMedGoogle Scholar
- Selby K, Nanchen D, Auer R, Gencer B, Räber L, Klingenberg R, Blum M, Marques-Vidal P, Cornuz J, Muller O, Vogt P, Jüni P, Matter CM, Windecker S, Lüscher TF, Mach F, Rodondi N (2015) Low statin use in adults hospitalized with acute coronary syndrome. Prev Med (Baltim) 77:131–136CrossRefGoogle Scholar